Exxon Mobil (XOM) fell out of the gate Wednesday after the energy giant warned investors that lower oil prices and refining margins will impact its fourth-quarter earnings, which will be released later this month.
In an 8-K filing with the Securities and Exchange Commission (SEC), Exxon Mobil said that it expects upstream earnings to decline by $500 million to $900 million from the third quarter due to declining liquid prices, according to MarketWatch.
Additionally, lower margins are expected to reduce its energy products earnings by $300 million to $700 million and its chemical products earnings by $300 million to $500 million.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
One positive is in its upstream segment, where higher gasoline prices are expected to increase earnings by up to $400 million.
Mizuho analyst Nitin Kumar responded by lowering his fourth-quarter earnings-per-share (EPS) forecast by 13% to $1.55. The analyst has a Neutral (Hold) rating on the energy stock.
MarketWatch noted that Exxon's warning came just a day after oil and gas company Shell (SHEL) gave a similar outlook in a 6-K filing.
Exxon said it expects to report its fourth-quarter earnings before the market opens on Friday, January 31.
Is Exxon Mobil stock a buy, sell or hold?
Exxon Mobil has lagged the broader market over the past 12 months, up 9.6% on a total return basis (price change plus dividends) vs the S&P 500's 27.5% gain. Yet, Wall Street remains bullish on the top dividend stock.
According to S&P Global Market Intelligence, the average analyst target price for XOM stock is $129.94, representing implied upside of about 21% to current levels. Meanwhile, the consensus recommendation is Buy.
Financial services firm UBS Global Research is one of the more bullish outfits on the blue chip stock with a Buy rating and a $147 price target.
In a note following the release of Exxon's 8-K filing, UBS Global Research analyst Josh Silverstein noted that the filing did "not include impacts from factors that have historically benefited XOM, including its growing Upstream volumes, ongoing cost reduction efforts, and its shift towards higher-value Downstream products."
However, he added that his firm may review its estimates following a discussion with Exxon.
Related content
-
H&R Block Must Revamp Practices and Pay $7 Million for Misleading Tax Filing ServicesTax Filing A tax prep industry giant was accused of deceiving customers and making downgrading difficult.
-
Moderna Stock Is Volatile Amid Bird Flu DevelopmentsModerna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you need to know.
-
Stock Market Today: Stocks Renew Rally Ahead of Mag 7 EarningsThe Dow Jones led the major indexes higher on the strength of old-school industrial stalwart 3M.
-
5 Stocks to Buy for a Trump PresidencyDonald Trump will be the 47th President of the United States. These five stocks are set to benefit from a second Trump administration.
-
Why You Should Invest in CommoditiesThese portfolio diversifiers are in a long-term uptrend and show why you should invest in commodities
-
Stock Market Today: Stocks Close Higher Ahead of Fed, May CPIMonday was a quiet session for the main indexes but this week's Fed meeting and a key inflation update could create fireworks.
-
Stock Market Today: Nasdaq Nabs New High as Nvidia Stock SoarsNvidia stock popped on a strong round of funding for Elon Musk's AI startup.
-
Stock Market Today: Markets Soar Amid Strong Earnings for Big Tech
Equities ended the week on an up note thanks to some of the market's biggest names.
-
Should You Use a 25x4 Portfolio Allocation?The 25x4 portfolio is supposed to be the new 60/40. Should you bite?
-
Where to Invest Now: TexasFolks should consider Texas when thinking about where to invest now, given its low cost of living, tech-savvy workforce and accommodating regulatory climate.
